NeuraStasis
Kirt Gill, MD is currently the CEO and Co-Founder of NeuraStasis, a company developing novel devices for patients with acute ischemic stroke. Prior to this, Kirt also served as a Clinical Advisor and Business Dev and R+D Specialist at Solenic Medical, an early stage medical device company. Additionally, Kirt has been involved in various roles at different companies, including being a Cohort Member at ZeroTo510 - Medical Device Accelerator and a Biodesign Fellow at Texas Medical Center. Kirt's educational background includes a BA in Molecular Biology and Classical Civilizations from the University of California, Berkeley, and a Doctor of Medicine (MD) from Keck School of Medicine of the University of Southern California.
This person is not in any teams
This person is not in any offices
NeuraStasis
NeuraStasis, Inc. is dedicated to the development of medical devices to improve the healthcare outcomes of patients who have suffered from a stroke. Through its proprietary non-invasive neurostimulation technology, NeuraStasis seeks to increase access to care for our most vulnerable populations and empower survivors to reclaim independence.